Vernx

About:

Biotechnology company targeting gut health.

Website: http://www.vernx.com

Description:

Building the foundation of a healthy gut. Branched fats are an important fatty acid found in human vernix caseosa and breast milk. It plays an important function in the developing infant gut epithelial, regulating immunity and seeding a healthy microbiota. Preterm infants and formula fed infants are deficient in branched fats which has significant negative health effects on gut health and immunity. Vernx Biotechnology will supply the global pharmaceutical, infant formula and supplement market with our proprietary branched fat active ingredients. Vernx Biotechnology is committed to providing science based medical foods to improve gastrointestinal health.

Total Funding Amount:

1.2M AUD

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Melbourne, Victoria, Australia

Founded Date:

2015-11-01

Contact Email:

Craig.patch(AT)vernx.com

Founders:

Craig Patch, Sarah Crennan, Tom Brenna

Number of Employees:

1-10

Last Funding Date:

2018-03-05

IPO Status:

Private

Industries:

© 2025 bioDAO.ai